These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 29737458)

  • 1. Dental Pulp Stem Cells - Exploration in a Novel Animal Model: the Tasmanian Devil (Sarcophilus harrisii).
    Graham CM; Kremer KL; Koblar SA; Hamilton-Bruce MA; Pyecroft SB
    Stem Cell Rev Rep; 2018 Aug; 14(4):500-509. PubMed ID: 29737458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii).
    Patchett AL; Flies AS; Lyons AB; Woods GM
    Cell Mol Life Sci; 2020 Jul; 77(13):2507-2525. PubMed ID: 31900624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii).
    Patchett AL; Coorens THH; Darby J; Wilson R; McKay MJ; Kamath KS; Rubin A; Wakefield M; Mcintosh L; Mangiola S; Pye RJ; Flies AS; Corcoran LM; Lyons AB; Woods GM; Murchison EP; Papenfuss AT; Tovar C
    Cell Mol Life Sci; 2020 May; 77(9):1847-1858. PubMed ID: 31375869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil (
    Weeratunga P; Shahsavari A; Fennis E; Wolvetang EJ; Ovchinnikov DA; Whitworth DJ
    Stem Cells Dev; 2020 Jan; 29(1):25-37. PubMed ID: 31709909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer.
    Murchison EP; Schulz-Trieglaff OB; Ning Z; Alexandrov LB; Bauer MJ; Fu B; Hims M; Ding Z; Ivakhno S; Stewart C; Ng BL; Wong W; Aken B; White S; Alsop A; Becq J; Bignell GR; Cheetham RK; Cheng W; Connor TR; Cox AJ; Feng ZP; Gu Y; Grocock RJ; Harris SR; Khrebtukova I; Kingsbury Z; Kowarsky M; Kreiss A; Luo S; Marshall J; McBride DJ; Murray L; Pearse AM; Raine K; Rasolonjatovo I; Shaw R; Tedder P; Tregidgo C; Vilella AJ; Wedge DC; Woods GM; Gormley N; Humphray S; Schroth G; Smith G; Hall K; Searle SM; Carter NP; Papenfuss AT; Futreal PA; Campbell PJ; Yang F; Bentley DR; Evers DJ; Stratton MR
    Cell; 2012 Feb; 148(4):780-91. PubMed ID: 22341448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin and carboplatin trials in Tasmanian devils (Sarcophilus harrisii) with Tasmanian devil facial tumor disease.
    Phalen DN; Frimberger AE; Peck S; Pyecroft S; Harmsen C; Lola S; Moore AS
    Vet J; 2015 Dec; 206(3):312-6. PubMed ID: 26538144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population.
    Pearse AM; Swift K; Hodson P; Hua B; McCallum H; Pyecroft S; Taylor R; Eldridge MD; Belov K
    Cancer Genet; 2012 Mar; 205(3):101-12. PubMed ID: 22469509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
    Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
    Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
    Tovar C; Patchett AL; Kim V; Wilson R; Darby J; Lyons AB; Woods GM
    PLoS One; 2018; 13(4):e0196469. PubMed ID: 29702669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1).
    Hayes DA; Kunde DA; Taylor RL; Pyecroft SB; Sohal SS; Snow ET
    PLoS One; 2017; 12(6):e0177919. PubMed ID: 28591206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of Cryptosporidium and Giardia from the Tasmanian devil (Sarcophilus harrisii).
    Wait LF; Fox S; Peck S; Power ML
    PLoS One; 2017; 12(4):e0174994. PubMed ID: 28423030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trials.
    Patchett AL; Tovar C; Blackburn NB; Woods GM; Lyons AB
    Immunol Cell Biol; 2021 Aug; 99(7):711-723. PubMed ID: 33667023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer.
    Murchison EP; Tovar C; Hsu A; Bender HS; Kheradpour P; Rebbeck CA; Obendorf D; Conlan C; Bahlo M; Blizzard CA; Pyecroft S; Kreiss A; Kellis M; Stark A; Harkins TT; Marshall Graves JA; Woods GM; Hannon GJ; Papenfuss AT
    Science; 2010 Jan; 327(5961):84-7. PubMed ID: 20044575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary mycobacteriosis caused by Mycobacterium intracellulare in a Tasmanian devil (Sarcophilus harrisii).
    Michael SA; Sangster CR
    Aust Vet J; 2010 Jul; 88(7):280-2. PubMed ID: 20579036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
    Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
    Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer- and behavior-related genes are targeted by selection in the Tasmanian devil (Sarcophilus harrisii).
    Hubert JN; Zerjal T; Hospital F
    PLoS One; 2018; 13(8):e0201838. PubMed ID: 30102725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human adenovirus encoding IFN-γ can transduce Tasmanian devil facial tumour cells and upregulate MHC-I.
    Kayigwe AN; M Darby J; Lyons AB; L Patchett A; Lisowski L; Liu GS; S Flies A
    J Gen Virol; 2022 Nov; 103(11):. PubMed ID: 36382885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible IFN-γ Expression for MHC-I Upregulation in Devil Facial Tumor Cells.
    Ong CEB; Lyons AB; Woods GM; Flies AS
    Front Immunol; 2018; 9():3117. PubMed ID: 30692995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Devil Facial Tumor Disease.
    Pye RJ; Woods GM; Kreiss A
    Vet Pathol; 2016 Jul; 53(4):726-36. PubMed ID: 26657222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditioned media from dental pulp stem cells improved diabetic polyneuropathy through anti-inflammatory, neuroprotective and angiogenic actions: Cell-free regenerative medicine for diabetic polyneuropathy.
    Makino E; Nakamura N; Miyabe M; Ito M; Kanada S; Hata M; Saiki T; Sango K; Kamiya H; Nakamura J; Miyazawa K; Goto S; Matsubara T; Naruse K
    J Diabetes Investig; 2019 Sep; 10(5):1199-1208. PubMed ID: 30892819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.